Skip to main content
. 2019 May 14;25(5):425–431. doi: 10.1089/tmj.2017.0299

Table 2.

Utilization of Pharmacotherapy, Counseling, Setting a Quit Date, and Discussion with Provider Prior and Immediately After the Intervention and 3-Month Follow-Up

PARTICIPANT CHARACTERISTICS (N = 162) PRIOR TO INTERVENTION (N = 162) INTEREST IMMEDIATELY AFTER INTERVENTION (N = 162) 3-MONTH FOLLOW-UP (N = 132)
Pharmacotherapy, n (%) 28 (17.3) 135 (83.3)a No data
Counseling, n (%) 16 (9.9) 151 (93.2) 26 (19.7)
Quitting, n (%) 102 (63.0)b 144 (88.9)c 31 (19.1)d
Discussion with provider, n (%) 58 (35.8) 156 (96.3)e No data
a

At least a 4 on a 0–10 scale of interest in using pharmacotherapy.

b

At least one previous quit attempt in the last 12 months.

c

Setting a quit date which is within the following 3 months.

d

Intention-to-treat analysis for self-reported 7-day point prevalence abstinence.

e

At least a 4 on a 0–10 scale of interest in quitting.